HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repositioning secnidazole as a novel virulence factors attenuating agent in Pseudomonas aeruginosa.

Abstract
Long-term treatment with antibiotics gives rise to the evolution of multi-drug resistant bacteria which are hard to be treated. Virulence factors inhibitors depend on disarming of microbial pathogens through reducing expression of virulence factors, abolishing the pathogen capability to harm the host. In the present study, the influence of secnidazole on Pseudomonas aeruginosa virulence factors expression was characterized. Production of Pseudomonas aeruginosa virulence factors such as pyocyanin, pyoverdin, elastase, rhamnolipids, proteases and hemolysins was examined following treatment of bacteria with sub-inhibitory concentration of secnidazole. Interestingly, secnidazole showed a powerful inhibitory effect on Pseudomonas aeruginosa virulence factors. Our results were further confirmed using qRT-PCR showing that there was a significant decrease in the expression of quorum sensing genes; lasI, lasR, rhlI, rhlR, pqsA and pqsR that regulate expression of virulence factors in Pseudomonas aeruginosa. Moreover, in vivo experiment using mice as infection model showed that secnidazole-treated bacteria were less capable to kill mice as compared to untreated bacteria. Importantly, there was a significant reduction in mortality in mice injected with secnidazole-treated bacteria relative to mice inoculated with untreated bacteria. In summary, our data showed that secnidazole could play a role in attenuating Pseudomonas aeruginosa through reducing virulence factors production. Moreover, our data clearly suggest that secnidazole could be involved in the treatment of Pseudomonas aeruginosa infections in order to control infection and lower the development of bacterial resistance to antibiotics.
AuthorsMoustafa M Saleh, Hisham A Abbas, Momen M Askoura
JournalMicrobial pathogenesis (Microb Pathog) Vol. 127 Pg. 31-38 (Feb 2019) ISSN: 1096-1208 [Electronic] England
PMID30500409 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • Anti-Infective Agents
  • Virulence Factors
  • Metronidazole
  • secnidazole
Topics
  • Animals
  • Anti-Infective Agents (pharmacology)
  • Disease Models, Animal
  • Drug Repositioning
  • Gene Expression Profiling
  • Metronidazole (analogs & derivatives, pharmacology)
  • Mice
  • Pseudomonas Infections (pathology)
  • Pseudomonas aeruginosa (drug effects, pathogenicity)
  • Real-Time Polymerase Chain Reaction
  • Survival Analysis
  • Virulence Factors (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: